205 related articles for article (PubMed ID: 36432299)
1. Targeting Ultrasmall Gold Nanoparticles with cRGD Peptide Increases the Uptake and Efficacy of Cytotoxic Payload.
Perrins RD; McCarthy LA; Robinson A; Spry KL; Cognet V; Ferreira A; Porter J; Garcίa CE; Rodriguez MÁ; Lopez D; Perera I; Conlon K; Barrientos A; Coulter T; Pace A; Hale SJM; Ferrari E; Bachrati CZ
Nanomaterials (Basel); 2022 Nov; 12(22):. PubMed ID: 36432299
[TBL] [Abstract][Full Text] [Related]
2. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the role of β1 integrin isoforms in cRGD-mediated uptake of nanoparticles bearing hydrophilized alkyne moieties in epithelial and endothelial cells.
Zhang W; Teske N; Samadi M; Sarem M; Shastri VP
Acta Biomater; 2020 Oct; 116():344-355. PubMed ID: 32871280
[TBL] [Abstract][Full Text] [Related]
4. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
5. α
Zhong P; Gu X; Cheng R; Deng C; Meng F; Zhong Z
Int J Nanomedicine; 2017; 12():7913-7921. PubMed ID: 29138558
[TBL] [Abstract][Full Text] [Related]
6. Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects.
Song Z; Lin Y; Zhang X; Feng C; Lu Y; Gao Y; Dong C
Int J Nanomedicine; 2017; 12():1941-1958. PubMed ID: 28331317
[TBL] [Abstract][Full Text] [Related]
7. Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.
Toti US; Guru BR; Grill AE; Panyam J
Mol Pharm; 2010 Aug; 7(4):1108-17. PubMed ID: 20527782
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
9. Profiling target engagement and cellular uptake of cRGD-decorated clinical-stage core-crosslinked polymeric micelles.
De Lorenzi F; Rizzo LY; Daware R; Motta A; Baues M; Bartneck M; Vogt M; van Zandvoort M; Kaps L; Hu Q; Thewissen M; Casettari L; Rijcken CJF; Kiessling F; Sofias AM; Lammers T
Drug Deliv Transl Res; 2023 May; 13(5):1195-1211. PubMed ID: 35816231
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of the antitumor efficacy of peptide-doxorubicin conjugates with different linkers.
Liang Y; Li S; Wang X; Zhang Y; Sun Y; Wang Y; Wang X; He B; Dai W; Zhang H; Wang X; Zhang Q
J Control Release; 2018 Apr; 275():129-141. PubMed ID: 29408580
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitization of ultrasmall GNP-PEG-cRGDfK in ALTS1C1 exposed to therapeutic protons and kilovoltage and megavoltage photons.
Enferadi M; Fu SY; Hong JH; Tung CJ; Chao TC; Wey SP; Chiu CH; Wang CC; Sadeghi M
Int J Radiat Biol; 2018 Feb; 94(2):124-136. PubMed ID: 29172866
[TBL] [Abstract][Full Text] [Related]
12. cRGD-functionalized nanoparticles for combination therapy of anti-endothelium dependent vessels and anti-vasculogenic mimicry to inhibit the proliferation of ovarian cancer.
Wang Y; Tong L; Wang J; Luo J; Tang J; Zhong L; Xiao Q; Niu W; Li J; Zhu J; Chen H; Li X; Wang Y
Acta Biomater; 2019 Aug; 94():495-504. PubMed ID: 31252171
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations of cRGD-conjugated PEGylated TiO
Siani P; Frigerio G; Donadoni E; Di Valentin C
J Colloid Interface Sci; 2022 Dec; 627():126-141. PubMed ID: 35842963
[TBL] [Abstract][Full Text] [Related]
14. Functional cRGD-Conjugated Polymer Prodrug for Targeted Drug Delivery to Liver Cancer Cells.
Zhou R; Zhang M; He J; Liu J; Sun X; Ni P
ACS Omega; 2022 Jun; 7(24):21325-21336. PubMed ID: 35755339
[TBL] [Abstract][Full Text] [Related]
15. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
Fu D; Huang X; Lv Z; Zhang Y; Chen M; Zhang W; Su D
Bioengineered; 2022 Mar; 13(3):7105-7117. PubMed ID: 35259049
[TBL] [Abstract][Full Text] [Related]
17. The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo.
Jang C; Lee JH; Sahu A; Tae G
Nanoscale; 2015 Nov; 7(44):18584-94. PubMed ID: 26489965
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide.
Kato N; Sato T; Fuchigami Y; Suga T; Geng L; Tsurumaru M; Hagimori M; Mukai H; Kawakami S
Eur J Pharm Sci; 2022 Sep; 176():106239. PubMed ID: 35714942
[TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography (PET) guided glioblastoma targeting by a fullerene-based nanoplatform with fast renal clearance.
Peng Y; Yang D; Lu W; Hu X; Hong H; Cai T
Acta Biomater; 2017 Oct; 61():193-203. PubMed ID: 28801268
[TBL] [Abstract][Full Text] [Related]
20. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes.
Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR
Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
